Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections

被引：79

作者：

Brown, Matthew F. ^{[1
]}

Reilly, Usa ^{[1
]}

Abramite, Joseph A. ^{[1
]}

Arcari, Joel T. ^{[1
]}

Oliver, Robert ^{[1
]}

Barham, Rose A. ^{[1
]}

Che, Ye ^{[2
]}

Chen, Jinshan Michael ^{[1
]}

Collantes, Elizabeth M. ^{[2
]}

Chung, Seung Won ^{[1
]}

Desbonnet, Charlene ^{[3
]}

Doty, Jonathan ^{[1
]}

Doroski, Matthew ^{[1
]}

Engtrakul, Juntyma J. ^{[4
]}

Harris, Thomas M. ^{[1
]}

Huband, Michael ^{[3
]}

Knafels, John D. ^{[5
]}

Leach, Karen L. ^{[4
]}

Liu, Shenping ^{[5
]}

Marfat, Anthony ^{[1
]}

Marra, Andrea ^{[3
]}

McElroy, Eric ^{[1
]}

Melnick, Michael ^{[1
]}

Menard, Carol A. ^{[6
]}

Montgomery, Justin I. ^{[1
]}

Mullins, Lisa ^{[3
]}

Noe, Mark. C. ^{[1
]}

O'Donnell, John ^{[3
]}

Penzien, Joseph ^{[3
]}

Plummer, Mark S. ^{[1
]}

Price, Loren M. ^{[1
]}

Shanmugasundaram, Veerabahu ^{[2
]}

Thoma, Christy ^{[3
]}

Uccello, Daniel P. ^{[1
]}

Warmus, Joseph S. ^{[1
]}

Wishka, Donn G. ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Worldwide Med Chem, Groton, CT 06340 USA

[2] Pfizer Global Res & Dev, Computat Chem, Groton, CT 06340 USA

[3] Pfizer Global Res & Dev, Antibacterials Res Unit, Groton, CT 06340 USA

[4] Pfizer Global Res & Dev, Drug Metab, Groton, CT 06340 USA

[5] Pfizer Global Res & Dev, Struct Biol, Groton, CT 06340 USA

[6] Pfizer Global Res & Dev, Primary Pharmacol, Groton, CT 06340 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2012年 / 55卷 / 02期

关键词：

ZINC-DEPENDENT DEACETYLASE; PLASMA-PROTEIN BINDING; UDP-3-O-(R-3-HYDROXYMYRISTOYL)-N-ACETYLGLUCOSAMINE DEACETYLASE; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; BAD BUGS; BIOSYNTHESIS; ANTIBIOTICS; MECHANISM; DESIGN;

D O I：

10.1021/jm2014748

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

In this paper, we present the synthesis and SAR as well as selectivity, pharmacokinetic, and infection model data for representative analogues of a novel series of potent antibacterial LpxC inhibitors represented by hydroxamic acid 1a.

引用

页码：914 / 923

页数：10

共 27 条

[1] METHOXY GROUP NONPLANARITY IN OMICRON-DIMETHOXYBENZENES - SIMPLE PREDICTIVE MODELS FOR CONFORMATIONS AND ROTATIONAL BARRIERS IN ALKOXYAROMATICS
ANDERSON, GM
KOLLMAN, PA
DOMELSMITH, LN
HOUK, KN
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1979, 101 (09) : 2344 - 2352
[2] Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9
[3] Uridine-Based Inhibitors as New Leads for Antibiotics Targeting Escherichia coli LpxC
Barb, Adam W.
Leavy, Tanya M.
Robins, Lori I.
Guan, Ziqiang
Six, David A.
Zhou, Pei
Bertozzi, Carolyn R.
Raetz, Christian R. H.
[J]. BIOCHEMISTRY, 2009, 48 (14) : 3068 - 3077
[4] Changes in plasma protein binding have little clinical relevance
Benet, LZ
Hoener, BA
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) : 115 - 121
[5] Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, Helen W.
Talbot, George H.
Bradley, John S.
Edwards, John E., Jr.
Gilbert, David
Rice, Louis B.
Scheld, Michael
Spellberg, Brad
Bartlett, John
[J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) : 1 - 12
[6] Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps:: Exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ
Chuanchuen, R
Beinlich, K
Hoang, TT
Becher, A
Karkhoff-Schweizer, RR
Schweizer, HP
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) : 428 - 432
[7] New Targets for Antibacterial Design: Kdo Biosynthesis and LPS Machinery Transport to the Cell Surface
Cipolla, L.
Polissi, A.
Airoldi, C.
Gabrielli, L.
Merlo, S.
Nicotra, F.
[J]. CURRENT MEDICINAL CHEMISTRY, 2011, 18 (06) : 830 - 852
[8] Refined solution structure of the LpxC-TU-514 complex and pKa analysis of an active site histidine:: Insights into the mechanism and inhibitor design
Coggins, BE
McClerren, AL
Jiang, L
Li, XC
Rudolph, J
Hindsgaul, O
Raetz, CRH
Zhou, P
[J]. BIOCHEMISTRY, 2005, 44 (04) : 1114 - 1126
[9] Structure of the Metal-Dependent Deacetylase LpxC from Yersinia enterocolitica Complexed with the Potent Inhibitor CHIR-090
Cole, Kathryn E.
Gattis, Samuel G.
Angell, Heather D.
Fierke, Carol A.
Christianson, David W.
[J]. BIOCHEMISTRY, 2011, 50 (02) : 258 - 265
[10] A new class of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitors for the treatment of Gram-negative infections: PCT application WO 2008027466
Cuny, Gregory D.
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (06) : 893 - 899

← 1 2 3 →